Davide Gori

Dr. Davide Gori

Department of Biomedical and Neuromotor Sciences, University of Bologna, 401261 Bologna, Italy
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2012 in Aging Cell
Verified
Journal Article
Open access
PDF file
PGPaolo Garagnani
Paolo Garagnani
MBMaria Giulia Bacalini
Maria Giulia Bacalini
CPChiara Pirazzini
Chiara Pirazzini
Davide GoriDavide Gori
Davide Gori
CGCristina Giuliani
Cristina Giuliani
CFClaudio Franceschi
Claudio Franceschi
Summary: The discovery of biomarkers able to predict biological age of individuals is a crucial goal in aging research. Recently, researchers' attention has turn toward epigenetic markers of aging. Using the Illumina Infinium HumanMethylation450 BeadChip on whole blood DNA from a small cohort of 64 subjects of different ages, we identified 3 regions, the CpG islands of ELOVL2, FHL2, and PENK genes, whose methylation level strongly correlates with age. These results were confirmed by the Sequenom's EpiTYPER assay on a larger cohort of 501 subjects from 9 to 99 years, including 7 cord blood samples. Among the 3 genes, ELOVL2 shows a progressive increase in methylation that begins since the very first stage of life (Spearman's correlation coefficient = 0.92) and appears to be a very promising biomarker of aging.

1 May 2014 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
AVAgnes M.M. Sonnenschein-Van der Voort
Agnes M.M. Sonnenschein-Van der Voort
LALidia R. Arends
Lidia R. Arends
JJJohan C. de Jongste
Johan C. de Jongste
IAIsabella Annesi-Maesano
Isabella Annesi-Maesano
SAS. Hasan Arshad
S. Hasan Arshad
LDLiesbeth Duijts
Liesbeth Duijts
Preterm birth, low birth weight, and infant catch-up growth seem associated with an increased risk of respiratory diseases in later life, but individual studies showed conflicting results. We performed an individual participant data meta-analysis for 147,252 children of 31 birth cohort studies to determine the associations of birth and infant growth characteristics with the risks of preschool wheezing (1-4 years) and school-age asthma (5-10 years). First, we performed an adjusted 1-stage random-effect meta-analysis to assess the combined associations of gestational age, birth weight, and infant weight gain with childhood asthma. Second, we performed an adjusted 2-stage random-effect meta-analysis to assess the associations of preterm birth (gestational age <37 weeks) and low birth weight (<2500 g) with childhood asthma outcomes. Younger gestational age at birth and higher infant weight gain were independently associated with higher risks of preschool wheezing and school-age asthma (P < .05). The inverse associations of birth weight with childhood asthma were explained by gestational age at birth. Compared with term-born children with normal infant weight gain, we observed the highest risks of school-age asthma in children born preterm with high infant weight gain (odds ratio [OR], 4.47; 95% CI, 2.58-7.76). Preterm birth was positively associated with an increased risk of preschool wheezing (pooled odds ratio [pOR], 1.34; 95% CI, 1.25-1.43) and school-age asthma (pOR, 1.40; 95% CI, 1.18-1.67) independent of birth weight. Weaker effect estimates were observed for the associations of low birth weight adjusted for gestational age at birth with preschool wheezing (pOR, 1.10; 95% CI, 1.00-1.21) and school-age asthma (pOR, 1.13; 95% CI, 1.01-1.27). Younger gestational age at birth and higher infant weight gain were associated with childhood asthma outcomes. The associations of lower birth weight with childhood asthma were largely explained by gestational age at birth.

13 August 2015 in Allergy
Verified
Journal Article
Closed access
PDF file
Gianvincenzo ZuccottiGianvincenzo Zuccotti
Gianvincenzo Zuccotti
FMF. Meneghin
F. Meneghin
Arianna AcetiArianna Aceti
Arianna Aceti
Giovanni BaroneGiovanni Barone
Giovanni Barone
MCM. L. Callegari
M. L. Callegari
TNThe Italian Society Of Neonatology
The Italian Society Of Neonatology

1 April 2020 in Journal of Science and Medicine in Sport
Verified
Journal Article
Closed access
Alice MasiniAlice Masini
Alice Masini
Sofia MariniSofia Marini
Sofia Marini
Davide GoriDavide Gori
Davide Gori
ELErica Leoni
Erica Leoni
ARAndrea Rochira
Andrea Rochira
LDLaura Dallolio
Laura Dallolio

13 April 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
CRChiara Reno
Chiara Reno
EMElisa Maietti
Elisa Maietti
MFMaria Pia Fantini
Maria Pia Fantini
ESElena Savoia
Elena Savoia
Lamberto ManzoliLamberto Manzoli
Lamberto Manzoli
Davide GoriDavide Gori
Davide Gori
In March 2021, the coronavirus disease 2019 (COVID-19) pandemic still poses a threat to the global population, and is a public health challenge that needs to be overcome. Now more than ever, action is needed to tackle vaccine hesitancy, especially in light of the availability of effective and safe vaccines. A cross-sectional online survey was carried out on a representative random sample of 1011 citizens from the Emilia-Romagna region, in Italy, in January 2021. The questionnaire collected information on socio-demographics, comorbidities, past vaccination refusal, COVID-19-related experiences, risk perception of infection, and likelihood to accept COVID-19 vaccination. Multiple logistic regression analyses and classification tree analyses were performed to identify significant predictors of vaccine hesitancy and to distinguish groups with different levels of hesitancy. Overall, 31.1% of the sample reported hesitancy. Past vaccination refusal was the key discriminating variable followed by perceived risk of infection. Other significant predictors of hesitancy were: ages between 35 and 54 years, female gender, low educational level, low income, and absence of comorbidities. The most common concerns about the COVID-19 vaccine involved safety (54%) and efficacy (27%). Studying the main determinants of vaccine hesitancy can help with targeting vaccination strategies, in order to gain widespread acceptance—a key path to ensure a rapid way out of the current pandemic emergency.

10 April 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
Marco MontaltiMarco Montalti
Marco Montalti
FRFlavia Rallo
Flavia Rallo
Federica GuaraldiFederica Guaraldi
Federica Guaraldi
LBLapo Bartoli
Lapo Bartoli
Giulia PoGiulia Po
Giulia Po
Davide GoriDavide Gori
Davide Gori
In the near future, COVID-19 vaccine efficacy trials in larger cohorts may offer the possibility to implement child and adolescent vaccination. The opening of the vaccination for these strata may play a key role in order to limit virus circulation, infection spreading towards the most vulnerable subjects, and plan safe school reopening. Vaccine hesitancy (VH) could limit the ability to reach the coverage threshold required to ensure herd immunity. The aim of this study was to investigate the prevalence and determinants of VH among parents/guardians toward a potentially available COVID-19 vaccination for children and adolescents. An online survey was performed in parents/guardians of children aged <18 years old, living in Bologna. Overall, 5054 questionnaires were collected. A vast majority (60.4%) of the parents/guardians were inclined to vaccinate, while 29.6% were still considering the opportunity, and 9.9% were hesitant. Highest vaccine hesitancy rates were detected in female parents/guardians of children aged 6–10 years, ≤29 years old, with low educational level, relying on information found in the web/social media, and disliking mandatory vaccination policies. Although preliminary, these data could help in designing target strategies to implement adherence to a vaccination campaign, with special regard to web-based information.